延迟增强MRI在非缺血性心脏病诊断中的应用
被引量:3
摘要
对比剂延迟增强MRI(delayed—enhancement magnetic resonance imaging,DE-MRI)既能够在体显示心肌瘢痕组织,又能够凭借其优异的空间分辨率明确非透壁性心肌梗死节段中梗死心肌占室壁厚度的比例,因此在缺血性心脏病的诊断、治疗及预后判断中发挥着不可替代的作用。近年来,这一在体组织学成像技术在非缺血性心脏病诊断中发挥的独特作用也倍受关注。
出处
《中华放射学杂志》
CAS
CSCD
北大核心
2008年第11期1227-1230,共4页
Chinese Journal of Radiology
参考文献30
-
1Mahrholdt H, Wagner A, Judd R, et ol. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J, 2005,26: 1461-1674.
-
2Crean A, Merchant N. MR perfusion and delayed enhancement imaging in the heart. Clin Radiol, 2006, 61 : 225-236.
-
3Marcu CB, Nijveldt R, Beek AM, et al. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease. Heart Lung Circ,2007,16 : 70-78.
-
4Jackson E, Bellenger N, Seddon M, et al. Ischaemic and nonischaemic cardiomyopathies : cardiac MRI appearances withdelayed enhancement. Clin Radiol,2007 ,62 :395-403.
-
5Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial irffarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol,2006, 47:2027-2033.
-
6Isbell DC, Kramer CM. Magnetic resonance for the assessment of myocardial viability. Curr Opin Cardiol, 2006,21:469-472.
-
7Sievers B, Elliott MD, Hurwitz LM, et al. Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation, 2007,115:236-244.
-
8Setser RM, Kim JK, Chung YC, et al. Cine delayed- enhancement MR imaging of the heart: initial experience. Radiology, 2006,239:856-862.
-
9Dewey M, Laule M, Taupitz M, et al. Myocardial viability: assessment with three-dimensional MR imaging in pigs and patients. Radiology, 2006,239:703-707.
-
10Choudhury L, Mahrholdt H, Wagner A. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coil Cardiol,2002,40: 2156-2164.
同被引文献31
-
1程流泉,高元桂,盛复庚,蔡幼铨.磁共振心脏成像平面的定位与解剖[J].中国医学影像学杂志,2004,12(5):321-324. 被引量:11
-
2Jackson E,Bellenger N,Seddon M,et al.Ischaemic and nonischaemic cardiomyopathies:cardiac MRI appearances with delayed enhancement[J] .Clin Radiol,2007,62 (5):395-403.
-
3Bongartz G,Golding S J,Jurik A G,et al.The 1999 CEC European Guidelines on Quality Criteria for Computed Tomography,EUR 16262 EN (2000)[J] .The Luxembourg Office for publication of the European Communities,Brussels,CEC,1999.
-
4Kim R J,Fieno D S,Parrish T B,et al.Relationship of MRI delayed contrast enhancement to irreversible injury,infarct age,and contractile function[J] .Circulation,1999,100(19):1992-2002.
-
5Ingkanisorn W P,Kwong R Y,Bohme N S,et al.Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain[J] .J Am Coil Cardiol,2006,47(7):1427-1432.
-
6Hunold P,Schlosser T,Vogt F M,et al.Myocardial late enhancement in contrast-enhanced cardiac MRI:distinction between infarction scar and non infarction-related disease[J] .A JR,2005,184(5):1420-1426.
-
7Vogel-Claussen J,Rochitte C E,Wu K C,et al.Delayed enhancement MR imaging:utility in myocardial assessment[J] .Radiographics,2006,26(3):795-810.
-
8Moon J C,McKenna W J,McCrohon J A,et al.Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance[J] .J Am Coll Cardiol,2003,41(9):1561-1567.
-
9Mewton N,Liu C Y,Croisille P,et al.Assessment of myocardial fibrosis with cardiovascular magnetic resonance[J] .J Am Coll Cardiol,2011,57(8):891-903.
-
10Jordan R M,Mintz R D.Fatal reaction to gadopentetate dimeglumine[J] .AJR,1995,164(3):743-744.
引证文献3
-
1郭冬玲,王利东.对比剂剂量优化在心脏MRI延迟强化扫描中的临床应用[J].实用放射学杂志,2014,30(9):1480-1482. 被引量:2
-
2张学强,相世峰,杨素君,侯博,董晓雷,杨震.心脏磁共振成像在左心室肥厚病变鉴别诊断中的价值[J].医学影像学杂志,2018,28(6):920-924. 被引量:19
-
3张艳,吴昆华,范洁,尚依一,刘罗,庞明杰.心脏磁共振成像在左心室肥厚性疾病中的应用[J].昆明理工大学学报(自然科学版),2020,45(1):59-64. 被引量:4
二级引证文献24
-
1郭乃才,赵玉霞.心脏核磁共振在室性心律失常诊治中的应用价值[J].中华全科医学,2019,17(2):265-268. 被引量:3
-
2张学强,相世峰,杨素君.心尖肥厚型心肌病病人MRI表现及心电图特点分析[J].中西医结合心脑血管病杂志,2017,15(10):1280-1282. 被引量:25
-
3李莉佳,付旷.心脏磁共振研究技术发展及其主要临床应用[J].实用放射学杂志,2017,33(11):1790-1792. 被引量:5
-
4欧阳裕锋,胡秋根,杜勇兴,刘子蔚.分析缺血性心肌病的心脏磁共振(CMR)特征性表现及诊断价值[J].影像研究与医学应用,2020,4(1):81-82. 被引量:2
-
5吴建敏,林加锋.心电图Peguero-Lo Presti电压标准诊断成人高血压相关性左室肥厚的价值[J].中华全科医学,2020,18(7):1169-1173. 被引量:6
-
6徐明.超声联合Tei指数评价尿毒症心肌病左室肥厚及形变对心功能的影响[J].医学影像学杂志,2020,30(5):767-771. 被引量:7
-
7王杨,刘鹏飞,刘凤岐,赵洪伟.心脏磁共振对硬膜外阻滞治疗心衰的疗效评价[J].医学影像学杂志,2020,30(6):977-980. 被引量:3
-
8张晓,赵猛,王静.心肌淀粉样变性MRI及临床特征分析(附4例报道)[J].医学影像学杂志,2020,30(6):981-983. 被引量:3
-
9苏瑾,朱永胜,罗秀霞,高磊,肖煦,杜牧.心脏磁共振和超声诊断肥厚性心肌病的价值[J].影像诊断与介入放射学,2020,29(3):167-170. 被引量:6
-
10何碧柳,蔡玮贤.动态心电图在高血压合并左心室肥厚患者中的临床研究[J].中国医药科学,2020,10(17):217-219. 被引量:7
-
1陈远刚,石丹,吴国祥.替米沙坦对高血压合并糖尿病患者血脂的影响[J].四川医学,2010,31(5):637-639. 被引量:2
-
2曹伟,赵彩彦.c-Jun氨基末端激酶与非酒精性脂肪性肝病[J].国际消化病杂志,2011,31(2):92-94. 被引量:2
-
3徐振羽,默军彩,张亚玲,吕奇志,刘丽宏.安体舒通治疗充血性心力衰竭的临床观察[J].中国冶金工业医学杂志,2003,20(1):28-28.
-
4李东法.思密达、奥美拉唑治疗上消化道出血疗效观察[J].吉林医学,2013,34(11):2068-2069.
-
5苏琼,叶真,倪海祥.中医药对胰岛β细胞作用的研究近况[J].浙江中医药大学学报,2009,33(2):286-287.
-
6代东伶,沈薇.解偶联蛋白2与非酒精性脂肪肝[J].中华肝脏病杂志,2004,12(9):574-576. 被引量:4
-
7喻晓东,卢岚.血液灌流并血液透析治疗急性重度有机磷中毒31例临床分析[J].重庆医学,2008,37(3):332-333. 被引量:22
-
8黄伟,陈君坤,苏宏,李峰,王大勇.电子束CT对复杂性先天性心脏病的诊断(附22例报告)[J].江苏医药,1999,25(8):587-588. 被引量:2
-
9王同成,唐元升,王际军.中药鸡尾酒疗法治疗不稳定型心绞痛疗效观察[J].山东医药,2006,46(31):65-66. 被引量:1
-
10申成宁,蔡迎茹.卡维地洛治疗慢性心力衰竭68例临床观察[J].中国煤炭工业医学杂志,2009,12(6):933-934. 被引量:1